戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 659751作成日:2026年10月23日

Piperazine Dihydrochloride → Irbesartan

https://huagongshe.com/ja/reaction/659751

反応式

関与物質

役割名称HCID仕込み量
反応物Piperazine DihydrochlorideHCID 8893—
反応物Sodium HydroxideHCID 14798—
反応物Sodium AzideHCID 33557—
反応物4'-((2-Butyl-4-oxo-1,3-diazaspiro(4.4)non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrileHCID 9843116—
溶媒WaterHCID 962—
溶媒DimethylformamideHCID 6228—
生成物IrbesartanHCID 374998%

反応手順

A mixture of 2-n-butyl-3-[(2′-cyanobiphenyl-4-yl)methyl]-1,3-diazaspiro-[4,4]-non-1-en-4-one (10 g), sodium azide (7.7 g) and piperazine dihydrochloride (7.5 g) in N,N-dimethylformamide (30 ml) was refluxed for 7 hours under stirring. The reaction was cooled to room temperature and 20 ml water was added. The reaction mixture was adjusted to pH of about 12 using 10% NaOH solution. The alkaline solution was washed with toluene (15 ml) and the aqueous phase was neutralized to pH of 6.5 using concentrated HCl. The resulting suspension was stirred for 3 hours at room temperature and filtered to obtain irbesartan (5.8 g, 98% purity by HPLC). Recrystallization of the Product using ethanol results in 5.2 g of irbesartan with 99.94% purity and content of the impurity 2-n-butyl-3-[(2′-carboxamidobiphenyl-4-yl)methyl]-1,3-diazaspiro-[4,4]-non-1-en-4-one: 0.07%.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US08080670B2
出典データセットuspto-grants-2011_12
ORD IDord-a87991bb691b4f3d9269906fa7cf021a
出典メモuspto-grants-2011_12